UiPath (PATH) stock analysis: Latest PATH stock price, earnings preview, technicals, valuation & forecast for Q4 2026 results. Is PATH stock a buy now?
Introduction
UiPath (PATH) stock powers enterprise automation software that uses AI to handle repetitive tasks. Investors watch PATH stock closely ahead of Q4 fiscal 2026 earnings on March 11, 2026. Broader market volatility from tech sector shifts and AI hype impacts PATH stock price trends.
PATH stock draws focus as analysts expect revenue growth amid agentic automation demand. Economic uncertainty pressures tech stocks like PATH.
Latest Stock Price & Trend
As of last market close on March 9, 2026, PATH stock price stands at around $11.34. The stock saw a 1-day dip amid pre-earnings caution.
Over 5 days, PATH stock price fell slightly on mixed volume. The 1-month trend shows sideways action near $11 support. In 3 months, it dropped 10% from peaks as AI peers cooled.
Six-month performance lags with a 15% decline from late 2025 highs. Year-to-date, PATH stock is down 20%, trading between 52-week high of $80 and low of $5. This bearish trend signals caution for short-term investors, but undervaluation hints at rebound potential.
Technical Analysis
Support levels sit at $10.50, where buyers stepped in recently. Resistance looms at $13, blocking upside moves. These levels matter as they show where price stalls or reverses.
RSI reading hovers at 45, neutral—not overbought above 70 or oversold below 30. MACD trend leans bearish with lines converging, suggesting weak momentum.
The 50-day moving average at $12 crosses below the 200-day at $15—no golden cross (bullish) or death cross (bearish) yet. Trading volume trends lower, indicating low conviction trades. Beginners note: these tools gauge if PATH stock forecast turns bullish.
Analyst Ratings & Price Targets
Of 15 analysts, 8 rate Buy, 5 Hold, 2 Sell on PATH stock. Average price target is $18, with high at $25 and low at $12. Recent upgrades from firms like Piper Sandler cite AI growth.
Wall Street sentiment leans positive for PATH earnings. This implies upside if results beat expectations, guiding everyday investors on risk.
Insider Activity
CEO Daniel Dines sold 45,000 shares on December 8, 2025, at premium prices. No major insider buying in Q1 2026. Trends show routine selling, not panic.
This suggests neutral confidence from management. Watch for post-earnings buys as a bullish PATH stock signal.
Valuation Analysis
Trailing P/E ratio is 26.33, forward P/E around 20 based on expected EPS growth. Price-to-sales sits low at 3x amid $1.43B FY revenue. YoY revenue growth projects at 12% to $1.78B in 2026.
EPS growth forecast: $0.25 for Q4. Free cash flow improves, debt low with strong cash reserves. Compared to Zoom (higher P/E) or Microsoft (premium valuation), PATH stock appears undervalued.
Recent Earnings & Catalysts
Q3 FY2026 showed revenue beat at $1.43B FY total, but EPS missed slightly. Q4 expectations: $465M revenue, $0.25 EPS on March 11 call. Guidance points to steady ARR growth.
Catalysts include AI agent launches and enterprise deals. Earnings dipped PATH stock 5% post-Q3, but beats could reverse that.
Bullish Case
PATH stock benefits from surging automation demand in enterprises. Revenue growth catalysts: 12% YoY to $1.78B in 2026. AI platform edges rivals in ease-of-use.
Operational tweaks boost margins. Market expansion into non-tech sectors fuels PATH forecast upside.
Bearish Case
Competition from Microsoft Copilot pressures PATH stock. Growth slowed to single digits last year. Margin squeezes from R&D spend loom.
Economic slowdown risks customer churn. Regulatory scrutiny on AI adds caution to PATH stock price.
Market Sentiment & Investor Psychology
Short interest at 5%, down recently. Options show balanced calls/puts. Institutional ownership steady at 60%, retail dips on forums.
Sentiment tilts neutral—momentum traders sit out, value hunters eye PATH valuation.
Short-Term Outlook
Technicals point to consolidation near $11 support. Pre-earnings volume may spike. Expect volatility around March 11 results—sideways unless beats ignite momentum.
Medium to Long-Term Outlook
UiPath’s agentic AI model thrives in growing automation market. Competitive moat via platform stickiness aids position. Financial health solid with cash buffer.
Long-term investors should hold or accumulate on dips, watching execution risks. PATH forecast: 50% upside to $18 average target.
FAQ Section
Is PATH stock a buy right now?
Neutral hold pre-earnings; buy on beats given undervaluation.
What is the price target for PATH stock?
Average $18, high $25 from analysts.
What are major risks for PATH stock?
Competition, slowing growth, macro slowdown.
PATH stock forecast for 2026?
Revenue to $1.78B, potential re-rating post-earnings.
What is PATH technical analysis summary?
Neutral RSI, bearish MACD—watch $10.50 support.
Suggestions
- Compare with Opendoor stock analysis
- See our Microsoft stock forecast
- Read tech sector valuation breakdown
Conclusion
Hold PATH stock ahead of March 11 earnings for clarity on growth. Undervalued metrics support accumulation, but risks warrant caution—no rush to buy.
Disclaimer: This article is for informational purposes only and not financial advice.